Bernard Esquivel, M.D., Ph.D.

Interim Co-Chair, G2MC

  • Personalized Medicine Latin American Association: President, LATAM
  • GenXys Healthcare Systems: Chief Medical Officer, Canada
    Ixlayer: Clinical Lead, USA
  • Harrisons Healthcare: Precision Medicine Senior Medical Advisor, Canada
  • NIH-NCBI Medical Genetic Summaries: Editorial Board, USA
  • Pharmacogenomics Research Network: Founder Member, USA

Bernard Esquivel is a practicing physician-scientist, senior executive, and international leader with in-depth expertise in developing new markets, devising compelling value propositions, go-to-market strategies, and launching programs to fulfill organizational goals and objectives in healthcare space, maintaining the highest alignment with the best regulatory practices. Bernard obtained his certifications from Harvard University in healthcare regulatory topics and applied artificial intelligence in healthcare. Clinical Immunologist, Allergies, and Medical Genetics by training with 12+ years experience in materializing biotech and health sciences ideas and concepts into clinically actionable solutions. Bernard mobilized the local healthcare community to engage them in the practice of precision medicine by founding and presiding over the Latin American Association of Personalized Medicine (ALAMP). This organization now includes >500 members from 9 countries in Latin America, holds symposiums, provider workshops, and other educational outreach per year. Serving as Chief Medical Officer for several well-renowned global organizations, he has demonstrated his passion and advocacy for bringing precision medicine & digital health closer to patients.

LinkedIn